Relapsed Chronic Lymphocytic Leukemia
EP. 1: Risk Stratification for CLL Settings & Typical Prognoses
January 8th 2019
EP. 2: Ibrutinib and Other Options for CLL
January 8th 2019
EP. 3: Venetoclax With Rituximab & Other Options After Relapse
January 8th 2019
EP. 4: MRD Negativity and Time-Limited Therapy
January 8th 2019
EP. 5: Venetoclax With Rituximab Treatment and Safety Profile
January 8th 2019
EP. 6: Options After Second Relapse and Unmet Needs in CLL
January 8th 2019
